OTC Markets OTCPK - Delayed Quote USD

Hemogenyx Pharmaceuticals Plc (HOPHF)

Compare
0.0031 0.0000 (0.00%)
At close: September 26 at 4:00 PM EDT
Advanced Chart
Loading Chart for HOPHF
DELL
  • Previous Close 0.0000
  • Open 0.0400
  • Bid 0.0031 x --
  • Ask 1.0000 x --
  • Day's Range 0.0400 - 0.0400
  • 52 Week Range 0.0031 - 0.0400
  • Volume 25,000
  • Avg. Volume 2,015
  • Market Cap (intraday) 30.032M
  • Beta (5Y Monthly) 3.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Sep 27, 2024 - Sep 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood cancer. The company's lead product candidate is the HEMO-CAR-T therapy for the treatment and potential cure for relapsed and/or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat COVID-19 virus, as well as to treat brain cancers and/or certain neurodegenerative diseases; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and cell therapy products for bone marrow/hematopoietic stem cell transplantation. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.

hemogenyx.com

17

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Hemogenyx Pharmaceuticals Plc

Recent News: HOPHF

View More
View More

Performance Overview: HOPHF

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HOPHF
92.25%
FTSE 100
7.50%

1-Year Return

HOPHF
92.25%
FTSE 100
9.02%

3-Year Return

HOPHF
89.42%
FTSE 100
17.89%

5-Year Return

HOPHF
97.93%
FTSE 100
23.08%

Compare To: HOPHF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

HOPHF
Hemogenyx Pharmaceuticals Plc
0.0031
0.00%
Mkt Cap 30.032M
Industry Biotechnology
AGNPF
Algernon Pharmaceuticals Inc.
0.0600
0.00%
Mkt Cap 1.822M
Industry Biotechnology
MEIP
MEI Pharma, Inc.
2.9000
+1.40%
Mkt Cap 19.322M
Industry Biotechnology
CRVS
Corvus Pharmaceuticals, Inc.
5.09
-2.12%
Mkt Cap 318.386M
Industry Biotechnology
GERN
Geron Corporation
4.4300
-1.77%
Mkt Cap 2.67B
Industry Biotechnology

Statistics: HOPHF

View More

Valuation Measures

Annual
As of 9/26/2024

  • Market Cap

    31.53M

  • Enterprise Value

    33.80M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.10

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -52.64%

  • Return on Equity (ttm)

    -222.31%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -6.69M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.25M

  • Total Debt/Equity (mrq)

    105.93%

  • Levered Free Cash Flow (ttm)

    -3.81M

View More

Company Insights: HOPHF

People Also Watch

LVCLF Algorae Pharmaceuticals Limited
0.0103
0.00%
 
PRNAF Alterity Therapeutics Limited
0.0036
0.00%
 
HMTXF Hemostemix Inc.
0.0729
0.00%
 
SLN Silence Therapeutics plc
17.43
-3.54%
 
SRBCF Sirona Biochem Corp.
0.0451
0.00%
 
TSBX Turnstone Biologics Corp.
0.5574
-2.18%
 
NGNE Neurogene Inc.
39.18
-6.56%
 
OPT Opthea Limited
4.0000
-3.85%
 
CSPHF CStone Pharmaceuticals
0.1920
0.00%
 
BXPHF Botanix Pharmaceuticals Limited
0.2890
-15.00%
 
CSTXF CryptoStar Corp.
0.0151
0.00%
 
MBXBF Microbix Biosystems Inc.
0.2530
0.00%
 
NTI.AX Neurotech International Limited
0.0590
-3.28%
 
ACOGF Alpha Cognition Inc.
0.4000
-0.02%
 
IMCR Immunocore Holdings plc
30.77
+0.36%